Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Lymphedema therapy may also boost sleep and Well-Being in breast cancer survivors

NCT ID NCT06697158

Symptom relief Sponsor: Abant Izzet Baysal University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looks at whether complex decongestive physiotherapy (CDP) can improve sleep quality and quality of life in women with stage 2 breast cancer-related lymphedema. CDP includes massage, skin care, compression bandages, and exercises. The study will follow 31 women for 4 weeks of intensive treatment plus a maintenance phase. Researchers will measure sleep using a standard questionnaire and quality of life with a lymphedema-specific tool.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
complex decongestive physiotherapy (manual lymphatic drainage, skin care, compression bandaging, and exercise)
What this could lead to
If successful, this could show that adding a maintenance phase to standard lymphedema therapy improves sleep and quality of life for women with stage 2 breast cancer-related lymphedema.
What could go wrong
This is a small, early-stage study with only 31 participants and no control group, so results may not apply to all patients. The therapy is already standard, so the main question is whether the maintenance phase adds extra benefit.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 31 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jan 2024

Expected to finish

Mar 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 85 years

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Participants must be aged between 18 or 85 years, * with a diagnosis of unilateral lymphedema in the upper extremity following breast cancer surgery * stage 2 lymphedema confirmed by a doctor * voluntary consent to participate in the study. Exclusion Criteria: * refusal to participate in the study * development of lymphedema due to primary causes, presence of bilateral upper extremity lymphedema * active soft tissue infection in the lymphedematous arm * mental or cognitive disorders * inability to communicate or cooperate * acute deep vein thrombosis, arterial insufficiency in the upper extremity, systemic diseases that could cause edema other than lymphedema (e.g., renal failure, liver failure, heart failure) * use of sleep medications or antidepressants

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Breast cancer-related lymphedema are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Breast Cancer Lymphedema insomnia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Breast cancer-related lymphedema

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    2 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Bolu Abant Izzet Baysal University

    NOT_YET_RECRUITING

    Bolu, 14030, Turkey (Türkiye)

  • Bolu Abant Izzet Baysal University

    RECRUITING

    Bolu, 14030, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.